| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |